HA15

Item no.	TMO-T6855-25mg
Manufacturer	TargetMol
CASRN	1609402-14-3
Amount	25 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 25 mg 2 mg 50 mg 5 mg
Category	Oncology Reagents & Chemicals Molecules By Organ Skin Cancer
Type	Molecules
Specific against	other
Citations	1.Cerezo M et al. Cancer Cell. 2016 Jun 13;29(6):805-19.
Smiles	CN(C)c1cccc2c(cccc12)S(=O)(=O)Nc1cccc(c1)-c1csc(NC(C)=O)n1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	GPR inhibitor,HSP inhibitor,inhibitor
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Apoptosis\|\|\|GPCR\|\|\|HSP\|\|\|Autophagy
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	466.58
Description	HA15 targets specifically BiP/GRP78/HSPA5. HA15 exhibits anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.
Pathways	Apoptosis\|\|\|Metabolism\|\|\|GPCR/G Protein\|\|\|Endocrinology/Hormones\|\|\|Autophagy\|\|\|Cytoskeletal Signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T6855-25mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 25 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question